Ring, J., Li, Y., Shapiro, I., Wang, Y., Weaver, D., & Pachter, J. (2015). FAK/PYK2 inhibitors defactinib and VS-4718 enhance immune checkpoint inhibitor efficacy. J Immunother Cancer.
Citação norma ChicagoRing, Jennifer, Yajuan Li, Irina Shapiro, Yan Wang, David Weaver, and Jonathan Pachter. "FAK/PYK2 Inhibitors Defactinib and VS-4718 Enhance Immune Checkpoint Inhibitor Efficacy." J Immunother Cancer 2015.
MLA CitationRing, Jennifer, et al. "FAK/PYK2 Inhibitors Defactinib and VS-4718 Enhance Immune Checkpoint Inhibitor Efficacy." J Immunother Cancer 2015.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.